Literature DB >> 26655613

COMPARING PERIPHERAL VITRECTOMY UNDER AIR AND FLUID INFUSION FOR PRIMARY RHEGMATOGENOUS RETINAL DETACHMENT.

Gurkan Erdogan1, Cihan Unlu, Bugra Karasu, Esra Kardes, Ahmet Ergin.   

Abstract

PURPOSE: To evaluate the efficacy and safety of peripheral vitrectomy under air infusion in comparison with fluid infusion in patients undergoing 23-gauge pars plana vitrectomy for primary rhegmatogenous retinal detachment.
METHODS: A total of 80 eyes of 80 patients with primary rhegmatogenous retinal detachment were enrolled into the study. Forty cases underwent peripheral vitrectomy under air infusion (air group), and a control group of equal number underwent peripheral vitrectomy under fluid infusion (fluid group). Peripheral iatrogenic retinal breaks during peripheral vitrectomy, postoperative visual acuities, and retinal redetachment rates were compared.
RESULTS: The number of eyes with peripheral iatrogenic retinal breaks in air group during peripheral vitrectomy was statistically comparable with that in fluid group (1/40 and 4/40, 2.5% and 10%, respectively; P = 0.16). Scleral depression was necessitated in 7 of 40 cases (17.5%) during the operation in the air group. There were no statistically significant differences between the groups in means of postoperative visual acuity and retinal redetachment (P = 0.18 and P = 1.0, respectively).
CONCLUSION: Peripheral vitrectomy under air infusion for primary rhegmatogenous retinal detachment revealed comparable results with fluid infusion in terms of intraoperative and postoperative complications and surgical outcomes.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26655613     DOI: 10.1097/IAE.0000000000000898

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  1 in total

1.  Outcomes of Vitrectomy Under Air for Idiopathic Macular Hole

Authors:  Murat Karaçorlu; Mümin Hocaoğlu; Işıl Sayman Muslubaş; M. Giray Ersöz; Serra Arf
Journal:  Turk J Ophthalmol       Date:  2019-12-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.